Biolab site choice flawed: report

A government report to be released later this week slams the plan to build a contested high security pathogen lab in Kansas, saying the Department of Homeland Security (DHS) did not properly evaluate the risks of conducting such research in the mainland, the linkurl:Washington Post reports.;http://www.washingtonpost.com/wp-dyn/content/article/2009/07/26/AR2009072602857_pf.html The report by the Government Accountability Office (GAO) said the idea of building the National Bio and Agro Defense F

Written byAlla Katsnelson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
A government report to be released later this week slams the plan to build a contested high security pathogen lab in Kansas, saying the Department of Homeland Security (DHS) did not properly evaluate the risks of conducting such research in the mainland, the linkurl:Washington Post reports.;http://www.washingtonpost.com/wp-dyn/content/article/2009/07/26/AR2009072602857_pf.html The report by the Government Accountability Office (GAO) said the idea of building the National Bio and Agro Defense Facility (NBAF) in Kansas, or in any mainland location, was not "scientifically defensible," according to the Post, and the DHS based its decision on a flawed risk assessment study. Critics have argued that such research should be done on an island to provide an extra measure of protection in case of accidental release, and objected to conducting research on agricultural pathogens in a region of the country crucial for the agricultural industry. Kansas, specifically, is prone to tornadoes, which could damage the facility and further raise the risk of contamination. Last May, the GAO came to a linkurl:similar conclusion;http://www.the-scientist.com/blog/display/54670/ about the prospect of moving research on foot-and-mouth disease from an aging facility on an island in New York to a mainland lab. "We found that [the] DHS has not conducted or commissioned any study" to assess whether FMD can be safely researched on the mainland, Nancy Kingsbury, managing director of applied research and methods at the GAO, said at a hearing then. The NBAF is part of the DHS's plan to modernize the country's biological and agricultural defense research, but has been dogged by controversy from the start. In April, a Texas group (who supported building the facility in Texas) cried foul at the selection process, claiming that aggressive lobbying and political cronyism had caused officials to overlook linkurl:the risk;http://www.the-scientist.com/blog/display/55664/ posed to such a lab by tornadoes frequent to Kansas. Kansas officials, however, have insisted that Kansas was selected on its merits in a fair and transparent process. The GAO report will be discussed at a Congressional hearing set for Thursday, July 30. According to the Post, DHS officials last week tried to avert the hearing, and told officials the GAO did not have the authority to review the DHS's risk assessment.
**__Related stories:__***linkurl:Texas to sue over biolab site;http://www.the-scientist.com/blog/display/55664/
[24th April 2009]*linkurl:Kansas wins controversial biolab?;http://www.the-scientist.com/blog/display/55260/
[4th December 2008]*linkurl:US homeland security to build animal biolab;http://www.the-scientist.com/news/display/23091/
[6th February 2006]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies